The Journal of Patient Safety, published by Lippincott Williams & Wilkins, is a premier scholarly journal dedicated to advancing the field of patient safety through empirical research, innovative practices, and critical insights. Established in 2006, this journal has rapidly gained recognition, currently holding a prestigious Q1 ranking in Leadership and Management and a Q2 ranking in Public Health, Environmental and Occupational Health for 2023, reflecting its significant impact within these disciplines. With an impressive rank of #7 in Nursing Leadership and Management and #211 in Medicine Public Health as recorded in Scopus, this journal serves as an essential resource for researchers, healthcare professionals, and students committed to improving patient safety and outcomes. The journal does not operate as an open access publication; however, its comprehensive scope and high-quality articles underscore its dedication to disseminating crucial knowledge in a field that is ever-evolving. Joining the readership of the Journal of Patient Safety means becoming part of a vital conversation aimed at redefining standards of care and enhancing safety protocols across various healthcare settings.

SAFETY SCIENCE, published by Elsevier in the Netherlands, is a premier international journal dedicated to advancing the fields of safety research, public health, environmental and occupational health, and risk management. With an impressive impact factor and recognized as a Q1 journal in multiple categories for 2023, its rigorous peer-reviewed articles are essential for researchers, professionals, and students alike. The journal covers a wide range of topics designed to influence safety practices and policies globally. Although Open Access options are not available, the substantial insights provided in each issue underscore the journal's critical role in enhancing the understanding of safety and risk dynamics in a constantly evolving world. With a convergence of knowledge from the years 1991 to 2025, SAFETY SCIENCE remains at the forefront of evidence-based research, stimulating essential dialogues and innovations that shape our approach to safety in various domains.

DRUGS & THERAPY PERSPECTIVES is an esteemed journal published by SpringerNature, dedicated to advancing knowledge in the field of pharmacology and therapeutic studies. With an ISSN of 1172-0360 and an E-ISSN of 1179-1977, this journal has been providing valuable insights since its inception in 1993 and continues to publish until 2024. Ranked in the Q3 category for Pharmacology (medical) and positioned within the 25th percentile according to Scopus rankings, it serves as a vital resource for researchers, practitioners, and students alike. Although it is not an open-access journal, it offers a comprehensive platform for innovative research, clinical practices, and evolving therapeutic strategies, reflecting the critical developments in drug therapy landscape. With its strategic emphasis on bridging academic studies and clinical applications, DRUGS & THERAPY PERSPECTIVES remains essential for those committed to enhancing drug efficacy and patient outcomes in the ever-evolving medical field.

Pediatric Quality & Safety is an esteemed Open Access journal aimed at enhancing the well-being and care of pediatric patients through rigorous research and innovative practices. Published by Lippincott Williams & Wilkins since 2016, this journal provides a platform for the dissemination of critical findings in the fields of pediatrics, perinatology, and child health, boasting a respectable impact factor that places it in the Q2 category for 2023, ranking #173 out of 330 in its field. With a commitment to improving healthcare outcomes, Pediatric Quality & Safety not only offers comprehensive coverage of current research trends but also promotes best practices among healthcare professionals. It welcomes contributions from researchers, clinicians, and students alike, making it an invaluable resource for anyone dedicated to advancing pediatric care. The journal is accessible for readers worldwide, reflecting a growing emphasis on open-access knowledge and collaboration.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, an esteemed publication in the field of pharmacology, is published by Wiley-Hindawi and has been at the forefront of clinical research since its inception in 1976. Operating primarily from the United Kingdom, this journal features a diverse array of articles that encompass both fundamental and practical aspects of clinical pharmacy, thereby supporting the advancement of therapeutic practices. With an ISSN of 0269-4727 and an E-ISSN of 1365-2710, it is indexed in key databases and holds respectable ranks within its categories; achieving Q3 in Pharmacology and Q2 in Medical Pharmacology in the latest quartile rankings. Its Scopus ranking reflects both its quality and relevance, being positioned in the 55th percentile for medical pharmacology and the 45th for pharmacology, toxicology, and pharmaceutics. Although it does not currently operate under an Open Access model, the journal's extensive readership and rigorous peer-review process ensure that the latest research reaches practitioners and academics alike. With a commitment to bridging the gap between pharmacological science and clinical practice, the JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS remains a critical resource for professionals striving to enhance patient outcomes through informed medication management.

Current Anesthesiology Reports is a prominent journal published by Springer Nature, dedicated to advancing the field of anesthesiology and pain medicine. With a focus on the latest clinical and research developments, this journal serves as a vital resource for researchers, clinicians, and students alike. As of 2023, it holds a respectable Q2 quartile ranking in its category, highlighting its impact and relevance within the discipline, while also ranking 59th out of 136 in Scopus, placing it in the 56th percentile for anesthesiology and pain medicine. The journal is indexed with the E-ISSN 2167-6275 and offers an open-access model that enhances visibility and accessibility of knowledge across the global medical community. Spanning research from 2013 to 2024, Current Anesthesiology Reports aims to contribute significantly to the understanding and practice of anesthesiology, reflecting the rapidly evolving landscape of the discipline.

Risk Management and Healthcare Policy is an esteemed Open Access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the fields of health policy and public health. Established in 2008, the journal fosters a rich dialogue among researchers, professionals, and students, focusing on innovative strategies for managing risks within healthcare systems. With a current impact factor reflected in its robust Scopus rankings—placing it in the top quartile (Q2) in both Health Policy and Public Health, Environmental and Occupational Health—the journal is a pivotal resource that shares critical insights and evidence-based practices. The journal not only covers empirical studies and analytical research but also promotes discussions on emerging challenges and opportunities within the healthcare sector. As a result, Risk Management and Healthcare Policy serves as a vital platform for disseminating high-quality research, fostering collaboration, and informing policy decisions aimed at enhancing health outcomes globally.

PHARMAZIE is a prestigious, peer-reviewed journal published by AVOXA-MEDIENGRUPPE DEUTSCHER APOTHEKER GMBH, focusing on the dynamic field of pharmaceutical science since its inception in 1947. With its ISSN 0031-7144 and a current impact factor placing it in the Q2 category of Pharmaceutical Science journals, PHARMAZIE has established itself as a pivotal resource for researchers, practitioners, and students alike. The journal emphasizes the dissemination of high-quality, original research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of knowledge and innovation in these fields. While currently not open access, the journal maintains a commendable Scopus rank of #94 out of 183 in its category, highlighting its relevance and appeal to the academic community. With a commitment to bridging the gap between research and practical applications, PHARMAZIE plays a crucial role in shaping the future of pharmaceutical practices and policies.

The Journal of Health and Safety at Work, published by the Iranian Occupational Health Association, is a vital resource for researchers, professionals, and students engaged in the fields of occupational health, safety, and environmental management. With an ISSN of 2251-807X and E-ISSN 2383-2088, this Open Access journal has been dedicated to disseminating knowledge since 2012, ensuring that critical research is accessible to a global audience. The journal’s scope encompasses a diverse range of topics including human factors and ergonomics, safety research, and public health, with a focus on enhancing workplace safety and environmental standards. Although currently positioned in the Q4 category across various disciplines within safety and health research, the journal offers a unique platform for emerging studies and innovative practices, making it a significant contributor to the discourse in these fields. The journal's commitment to open access aligns with the growing trend of transparent scholarship, thus facilitating the sharing of vital insights to improve workplace health and safety outcomes. Researchers aiming to publish groundbreaking studies in this pivotal area will find the Journal of Health and Safety at Work an indispensable avenue for advancing knowledge and fostering professional collaboration.

Safety is a prestigious Open Access journal published by MDPI, based in Switzerland, dedicated to advancing research in the fields of public health, environmental safety, and occupational health. Since its inception in 2015, the journal has become a vital resource for researchers, practitioners, and policymakers, striving to foster innovative solutions to safety challenges in various sectors. With its rigorous peer-review process and a 2023 ranking in the Q2 category for Safety Research, as well as a notable presence in public health and environmental disciplines, Safety is well-respected in academic circles, holding a Scopus rank of 37/109 in Safety Research and 87/207 in Safety, Risk, Reliability, and Quality. The journal aims to disseminate high-quality research that not only reflects the latest advancements but also aids in developing practical strategies for risk management and safety improvement. Supported by an open-access model, Safety ensures that cutting-edge research is readily available to a global audience, fostering collaboration and knowledge sharing for a safer environment.